Medicaments for tumour therapy - contg. trace elements, glycine, glycerol, ascorbic acid, tetra:halo-fluorescein, EDTA and tartrate

摘要

Aq. pharmaceutical compsns., esp. for tumour therapy, comprise (a) a mixt. of water soluble B, F, Mg, V, Mn, Fe, Co, Ni, Cu, Zn and Mo cpds. which do not ppte. with one another or with the other components of the compsn. and which provide an acid or neutral pH; (b) glycine; (c) glycerol; (d) ascorbic acid; (e) a water-soluble neutral or acid salt of a 2,4,5,7-tetrahalofluorescein; (f) a water-soluble neutral or acid salt of ethylenediaminetetracetic acid (EDTA); and (g) Na and K double tatrate. These components are formulated with H2O and opt. other carriers, diluents and/or additives. The compsns. can be used for treatment or prophylaxis of a wide range of malignant tumours. They have no harmful side-effects and, as well as causing tumour regression, they have favourable effects and, as well as causing tumour regression, they have favourable effects on nausea, osteoporosis, pain, fatigue, insomnia, anaemia, hair loss and other symptoms.